Uncovering the differential impact of ESR1 and PIK3CA codon variants on the clinical phenotype of metastatic breast cancer (MBC) through circulating tumor DNA (ctDNA) next-generation sequencing (NGS).

被引：2
|
作者：
Gerratana, Lorenzo
Davis, Andrew A.
Velimirovic, Marko
D'Amico, Paolo
Shah, Ami N.
Clifton, Katherine
Zhang, Qiang
Dai, Charles Sichao
Reduzzi, Carolina
Hensing, Whitney L.
Bonotto, Marta
Mazzeo, Roberta
Wehbe, Firas Hazem
Franzoni, Alessandra
Belletti, Barbara
Behdad, Amir
Ma, Cynthia X.
Puglisi, Fabio
Bardia, Aditya
Cristofanilli, Massimo
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Med Hematol & Oncol, Chicago, IL 60611 USA
[2] Univ Udine, Dept Med DAME, Chicago, IL USA
[3] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[4] Harvard Med Sch, Boston, MA 02115 USA
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Chicago, IL 60611 USA
[7] Washington Univ, Sch Med, St Louis, MO 63110 USA
[8] Northwestern Univ, Lurie Canc Ctr, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA
[9] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[10] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[11] Univ Hosp Udine, Dept Oncol, Udine, Italy
[12] Univ Udine, Dept Med Area, Udine, Italy
[13] CRO Aviano, IRCCS, Dept Med Oncol, Udine, Italy
[14] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[15] Azienda Sanitaria Univ Friuli Cent ASUFC, Inst Human Genet, Udine, Italy
[16] IRCCS, Ctr Riferimento Oncol Aviano CRO, Unit Mol Oncol, Aviano, Italy
[17] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA
[18] Univ Udine, Dept Med DAME, Udine, Italy
[19] IRCCS, Ctr Riferimento Oncol Aviano CRO, Dipartimento Oncol Med, Udine, Italy
[20] Harvard Med, Massachusetts Gen Hosp, Boston, MA USA
[21] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.1033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1033
引用
收藏
页数：3
相关论文
共 39 条
  • [1] Exploring the interplay among ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype of metastatic breast cancer (MBC) through circulating tumor DNA (ctDNA) next-generation sequencing (NGS)
    Gerratana, Lorenzo
    Davis, Andrew A.
    Velimirovic, Marko
    Clifton, Katherine
    Hensing, Whitney L.
    Shah, Ami N.
    Dai, Charles S.
    Reduzzi, Carolina
    D'Amico, Paolo
    Zhang, Qiang
    Wehbe, Firas
    Wander, Seth
    Gradishar, William J.
    Behdad, Amir
    Puglisi, Fabio
    Ma, Cynthia X.
    Bardia, Aditya
    Cristofanilli, Massimo
    CANCER RESEARCH, 2022, 82 (04)
  • [2] Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
    Gerratana, Lorenzo
    Davis, Andrew A.
    Velimirovic, Marko
    Clifton, Katherine
    Hensing, Whitney L.
    Shah, Ami N.
    Dai, Charles S.
    Reduzzi, Carolina
    D'Amico, Paolo
    Wehbe, Firas
    Medford, Arielle
    Wander, Seth A.
    Gradishar, William J.
    Behdad, Amir
    Puglisi, Fabio
    Ma, Cynthia X.
    Bardia, Aditya
    Cristofanilli, Massimo
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [3] Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
    Lorenzo Gerratana
    Andrew A. Davis
    Marko Velimirovic
    Katherine Clifton
    Whitney L. Hensing
    Ami N. Shah
    Charles S. Dai
    Carolina Reduzzi
    Paolo D’Amico
    Firas Wehbe
    Arielle Medford
    Seth A. Wander
    William J. Gradishar
    Amir Behdad
    Fabio Puglisi
    Cynthia X. Ma
    Aditya Bardia
    Massimo Cristofanilli
    Breast Cancer Research, 25
  • [4] Concordance of circulating tumor DNA (ctDNA) and next-generation sequencing (NGS) as molecular monitoring tools in metastatic breast cancer (MBC)
    Austin, Laura K.
    Avery, Tiffany
    Jaslow, Rebecca
    Fortina, Paolo
    Sebisanovic, Dragan
    Siew, LaiMun
    Zapanta, Aubrey
    Talasaz, AmirAli
    Cristofanilli, Massimo
    CANCER RESEARCH, 2015, 75
  • [5] Investigating oncogenic signaling pathways in inflammatory metastatic breast cancer (MBC) though circulating tumor DNA (ctDNA) next-generation sequencing (NGS)
    Gerratana, Lorenzo
    Davis, Andrew A.
    Mina, Marco
    Jacob, Saya L.
    Zhang, Qiang
    Shah, Ami N.
    D'Amico, Paolo
    Katam, Neelima
    Wehbe, Firas
    Vagia, Elena
    Flaum, Lisa
    Platanias, Leonidas
    Behdad, Amir
    Puglisi, Fabio
    Gradishar, William J.
    Ciriello, Giovanni
    Cristofanilli, Massimo
    CANCER RESEARCH, 2021, 81 (04)
  • [6] Landscape of ESR1 mutations in advanced breast cancer using circulating tumor DNA (ctDNA) next-generation sequencing (NGS) in Asia and Middle East (AME)
    Dawood, S.
    Al Akasheh, M.
    Peretz-Yablonski, T.
    Ben-Baruch, N. E.
    Sandhir, N.
    Jain, S. S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1487 - S1487
  • [7] Dynamic development of ESR1 mutations in circulating tumor DNA (ctDNA) is associated with prognosis of patients with metastatic breast cancer (MBC)
    Zhang, Qiang
    Jiao, Jianhua
    Gerratana, Lorenzo
    D'Amico, Paolo
    Singhal, Seema
    Zhang, Youbin
    Davis, Andrew A.
    Shah, Ami N.
    Gradishar, William
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Concordance between tissue (tumor DNA) and liquid (ctDNA) biopsy next-generation sequencing (NGS) data in detection of PIK3CA, AKT1, and PTEN alterations in breast cancer: A retrospective analysis
    Vasan, Neil
    Chaki, Moumita
    Benrashid, Mona
    Puri, Subir
    Sivakumar, Smruthy
    Sokol, Ethan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] PIK3CA and ESR1 mutations detected in circulating tumor DNA (ctDNA) are predictive factors for late-line hormone-based therapies in ER+/HER2-metastatic breast cancer (MBC)
    Chen, Tom Wei-Wu
    Dai, Ming-Shen
    Chang, Dwang-Ying
    Lin, Ching-Hung
    Chen, I-Chun
    Wang, Ming-Yang
    Huang, Ling-Yi
    Hsu, An
    Zhuo, De-Wei
    Tan, Kien Thiam
    Lu, Yen-Jung
    Chang, Shu-Han
    Cheng, Ann-Lii
    Lu, Yen-Shen
    CANCER RESEARCH, 2020, 80 (04)
  • [10] ESR1 mutations in circulating tumor DNA (ctDNA) are associated with CTCs and increased hormone receptors in metastatic tumor tissues of patients with metastatic breast cancer (MBC).
    Zhang, Qiang
    Qin, Weijun
    D'Amico, Paolo
    Jiao, Jianhua
    Davis, Andrew A.
    Gerratana, Lorenzo
    Donahue, Jeannine
    Reduzzi, Carolina
    Manai, Marwa
    Jacob, Saya
    Zhang, Youbin
    Flaum, Lisa E.
    Behdad, Amir
    Cristofanilli, Massimo
    Platanias, Leonidas C.
    Shah, Ami N.
    Gradishar, William John
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
1234